Clusterin (CLU) protein is widely distributed in animal tissues and is involved in many different processes, including apoptosis and neoplastic transformation. Green tea catechins (GTC) are known to exert chemopreventive effects in many cancer models, including transgenic adenocarcinoma mouse prostate (TRAMP) mice that spontaneously develop prostate cancer (CaP). We report here that growth of SV40-immortalized human prostate epithelial cells (PNT1A) as well as tumorigenic, poorly differentiated prostate cancer cells (PC-3) was potently inhibited by EGCG, the major green tea catechin, while normal human prostate epithelial cells were not significantly affected. IC(50) doses of EGCG for 24 h caused caspase cascade activation and CLU protein accumulation in both cells lines but not in normal cells, in which CLU remained undetectable. While 100% of TRAMP mice developed CaP, only 20% of those receiving 0.3% GTC in drinking water developed the neoplasm. In TRAMP mice, the CLU gene was dramatically down-regulated during onset and progression of CaP. In GTC-treated TRAMP mice in which tumor progression was chemoprevented, CLU mRNA and protein progressively accumulated in the prostate gland. CLU dropped again to undetectable levels in animals in which GTC chemoprevention failed and CaP developed. Up-regulation of histone H3 and down-regulation of growth arrest-specific gene 1 (Gas1) mRNAs in CaP-developing TRAMP mice demonstrated a high proliferation rate in tumors, while the opposite occurred in the glands of GTC chemoprevented animals. Failure of GTC chemoprevention caused induction of both histone H3 and Gas1 and down-regulation of CLU. Immunohistochemistry experiments confirmed CLU down-regulation during CaP onset and progression, and CLU sustained expression in chemoprevented TRAMP mice. A possible role for CLU as a novel tumor-suppressor gene in the prostate is thus suggested.

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgh235DOI Listing

Publication Analysis

Top Keywords

tramp mice
24
clu
10
prostate
8
clu protein
8
green tea
8
prostate cancer
8
human prostate
8
prostate epithelial
8
epithelial cells
8
onset progression
8

Similar Publications

This study investigated tempol action on genes and miRNAs related to NFκB pathway in androgen dependent or independent cell lines and in TRAMP model in the early and late-stages of cancer progression. A bioinformatic search was conducted to select the miRNAs to be measured based on the genes of interest from NFκB pathway. The miR-let-7c-5p, miR-26a-5p and miR-155-5p and five target genes (BCL2, BCL2L1, RELA, TNF, PTGS2) were chosen for RT-PCR and gene enrichment analyses.

View Article and Find Full Text PDF

Plasmodium knowlesi, primarily a zoonotic malaria species is the most common malaria pathogen in the Southeast Asia especially in Malaysian Borneo, Malaysia. Due to morphological resemblance of P. knowlesi to other human Plasmodium, the sensitivity for microscopic detection of P.

View Article and Find Full Text PDF
Article Synopsis
  • Previous research indicated that the MRI probe GdL1 can differentiate between healthy and cancerous prostate tissues based on zinc levels.
  • Mice were given varying zinc diets for three weeks, and their prostate zinc secretion was analyzed using advanced imaging techniques.
  • Results showed that healthy mice effectively regulated zinc levels, while cancerous mice struggled, suggesting that zinc supplements before imaging could improve prostate cancer detection accuracy.
View Article and Find Full Text PDF
Article Synopsis
  • * Activating innate immunity through RIG-I-like receptors (RLRs), which sense RNA and promote inflammatory responses, could enhance immune surveillance in PCa.
  • * The study finds that while RLRs are more active in early-stage PCa, their signaling decreases in advanced stages; using a RIG-I agonist can induce tumor cell apoptosis and improve immune responses, suggesting a potential new treatment approach.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!